Details for New Drug Application (NDA): 206910
✉ Email this page to a colleague
The generic ingredient in JADENU is deferasirox. There are twenty drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the deferasirox profile page.
Summary for 206910
Tradename: | JADENU |
Applicant: | Novartis Pharms Corp |
Ingredient: | deferasirox |
Patents: | 1 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 206910
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
JADENU | deferasirox | TABLET;ORAL | 206910 | NDA | Novartis Pharmaceuticals Corporation | 0078-0654 | 0078-0654-15 | 30 TABLET, FILM COATED in 1 BOTTLE (0078-0654-15) |
JADENU | deferasirox | TABLET;ORAL | 206910 | NDA | Novartis Pharmaceuticals Corporation | 0078-0655 | 0078-0655-15 | 30 TABLET, FILM COATED in 1 BOTTLE (0078-0655-15) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 90MG | ||||
Approval Date: | Mar 30, 2015 | TE: | AB | RLD: | Yes | ||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Nov 21, 2034 | Product Flag? | Y | Substance Flag? | Y | Delist Request? |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 180MG | ||||
Approval Date: | Mar 30, 2015 | TE: | AB | RLD: | Yes | ||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Nov 21, 2034 | Product Flag? | Y | Substance Flag? | Y | Delist Request? |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 360MG | ||||
Approval Date: | Mar 30, 2015 | TE: | AB | RLD: | Yes | ||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Nov 21, 2034 | Product Flag? | Y | Substance Flag? | Y | Delist Request? |
Expired US Patents for NDA 206910
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis Pharms Corp | JADENU | deferasirox | TABLET;ORAL | 206910-003 | Mar 30, 2015 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis Pharms Corp | JADENU | deferasirox | TABLET;ORAL | 206910-002 | Mar 30, 2015 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis Pharms Corp | JADENU | deferasirox | TABLET;ORAL | 206910-001 | Mar 30, 2015 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis Pharms Corp | JADENU | deferasirox | TABLET;ORAL | 206910-002 | Mar 30, 2015 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis Pharms Corp | JADENU | deferasirox | TABLET;ORAL | 206910-003 | Mar 30, 2015 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription